G

Garvan Institute of Medical Research

Genetic disease-focused biomedical research institute

Faculty in Cancer Research

Full-Time
No salary listed
Expert
Sydney NSW, Australia
In Person
Academic & Institutional ResearchLife Sciences Research

About the job

Requirements
  • Applicants should complement existing research interests, areas of strength, and international partnerships.
  • Research grounded in field cancerisation, clonal and somatic evolution, cell competition, or ecological oncology is of particular interest.
  • Applicants should be scientists or clinician scientists interested in solving fundamental biological questions.
  • Applicants should have a clear research vision, demonstrated aptitude for independent and creative thinking, and a strong track record of high-quality scientific output relative to opportunity and career stage.
  • The successful candidate should contribute to program-specific cancer questions.
Responsibilities
  • Contribute to multidisciplinary collaborations across the Garvan Institute and with other national and international institutions.
  • Pursue independent discovery research supported by a start-up package.
Desired Qualifications
  • Research interests in developmental biology, genetics/genomics, systems biology, or immunology as applied to cancer research.

About the company

G

Garvan Institute of Medical Research

View

Garvan Institute of Medical Research conducts biomedical research to understand how genes, molecules, and cells influence health and disease, aiming to prevent and treat major illnesses. It combines fundamental science with strong clinical collaborations to translate discoveries into medical advances. What sets Garvan apart is its sustained, long-term work that integrates laboratory research with direct clinical interactions across a range of diseases, not just one specialty. Its goal is to prevent, treat, or cure major diseases such as cancer, diabetes/obesity, neurological disorders, osteoporosis, and immunological diseases by uncovering mechanisms and developing new therapies.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Sydney, Australia

Founded

1963

Get referred to Garvan Institute of Medical Research

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • NHMRC awarded Garvan’s autoimmune centre funding on 7 September 2026, extending five-year support.
  • Garvan secured NHMRC funding boosts on 10 August 2026 for genomic and immune discoveries.
  • Garvan announced new cancer labs and recruitment in August 2026, signaling continued scientific expansion.

What critics are saying

  • Garvan’s revenue depends on grants and philanthropy; one funding gap can freeze programs quickly.
  • Revelio shows 663 employees in March 2026 and only 16 postings, signaling hiring caution.
  • If translational bets like PatientSeek or CAR-T fail, Garvan remains a research-only cost center.

What makes Garvan Institute of Medical Research unique

  • Garvan’s autoimmune CRE under Chris Goodnow targets somatic mutation biology, not generic immunology.
  • Its Genomics Platform joined Parse Biosciences in July 2026, expanding regional single-cell access.
  • Garvan pairs discovery research with clinical trial networks, including Parkinson’s stratification and cancer studies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Parental Leave
  • Flexible Work Hours
  • Professional Development Budget
  • Conference Attendance Budget
  • Employee Discounts

Company News

BioSpace
Feb 22nd, 2023
C4Xd And Garvan Institute Of Medical Research Report Successful Patient Stratification Approach Using C4Xd'S New Precision Medicine Platform Patientseek

First validation of C4XD's patient sub-groups through a Garvan-led retrospective clinical trial analysis. Promising initial result paves way for novel approaches in Parkinson's disease stratification. Launch of PatientSeek platform enables stratification of patients to identify the right patient for the right medicine